Please assess the completion status of the following clinical trial:

Trial Title: Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Greater than 12 hrs of age and less than 10 days chronologic age~* 501-1000 gm~* Intubated and mechanically ventilated before 12 hrs~* Indwelling vascular catheter~* Infants 751-100 gm must be receiving FiO2 greater than 0.30 and have received at least 1 dose of surfactant at randomization~* Parental consent~Exclusion Criteria:~* Major congenital anomaly~* Symptomatic non-bacterial infection~* Permanent neuromuscular conditions that affect respiration~* Terminal illness (defined as pH values less than 6.8 for more than 2 hours or persistent bradycardia associated with hypoxia for more than 2 hours)~* Use of postnatal corticosteroids

- Gender: ALL
- Minimum Age: 5 Minutes
- Maximum Age: 10 Days
- Healthy Volunteers: f

Study Arms:
- Minimal ventilation with Dexamethasone (Type: EXPERIMENTAL): Minimal ventilator support strategy (permissive hypercapnia) and early stress dose dexamethasone therapy
- Minimal Ventilation without Dexamethasone (Type: EXPERIMENTAL): Minimal ventilator support strategy (permissive hypercapnia) and no dexamethasone therapy
- Routine ventilation with Dexamethasone (Type: ACTIVE_COMPARATOR): None
- Routine ventilation without Dexamethasone (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).